U.S. Gout Therapeutics Market Benefits from Rising Awareness and...

ha aggiunto una foto Altre informazioni

2026-06-16 06:29:06 - Translate -

U.S. Gout Therapeutics Market Benefits from Rising Awareness and Early Diagnosis Initiatives

The U.S. gout therapeutics market, valued at USD 1.40 billion in 2024, is anticipated to expand at a CAGR of 6.9% from 2025 to 2034, with growth increasingly driven by segment-wise performance across product types, treatment phases, and therapeutic platforms. The market can be segmented by product type into urate-lowering therapies (ULTs), anti-inflammatory agents, and emerging biologics, with...

0 Commenti 0 condivisioni 38 Views 0 Anteprima